1Velenik V;Anderluh F;Oblak I.Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer:prospective phase II trial,2006(05).
2Kim JC;Kim TW;Kim JH.Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer,2005(02).
3Bosset JF,Collette L,Calais G,Mineur L,Maingon P,Radosevic-Jelic L,Daban A,Bardet E,Beny A,Ollier JC.Chemotherapy with preoperative radiotherapy in rectal cancer. The New England Journal of Medicine . 2006
4Pasquale Comella,Bruno Massidda,Gianfranco Filippelli,Antonio Farris,Donato Natale,Giuseppe Barberis,Luigi Maiorino,Sergio Palmeri,Michele Cannone,Giovanni Condemi.Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401[J]. Journal of Cancer Research and Clinical Oncology . 2009 (2)
5Tetsuhiko Shirasaka,Susumu Yamamitsu,Akihito Tsuji,Tetsuo Taguchi.Conceptual Changes in Cancer Chemotherapy: From an Oral Fluoropyrimidine Prodrug, UFT, to a Novel Oral Fluoropyrimidine Prodrug, S-1, and Low-Dose FP Therapy in Japan[J]. Investigational New Drugs . 2000 (4)
6Van Cutsem E,Findlay M,Osterwalder B,Kocha W,Dalley D,Pazdur R,Cassidy J,Dirix L,Twelves C,Allman D,Seitz JF,Sch?lmerich J,Burger HU,Verweij J.Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study. Journal of Clinical Oncology . 2000
7Cartwright TH,,Encarnacion C,Vukelja SJ.A phase II openlabel study of capecitabine in combination with irinotecan as first-line treatment for metastatic colorectal cancer. Proceedings of the American Society of Clinical Oncology . 2004
8Rosati G,,Cordio S,Bordonaro R,Caputo G,Novello G,Reg- giardo G,Manzione L.Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomized phase II study. Annals of Oncology . 2010
9Khne CH,De Greve J,Hartmann JT,Lang I,Vergauwe P,Becker K,Braumann D,Joosens E,Müller L,Janssens J,Boke- meyer C,Reimer P,Link H,Sp?th-Schwalbe E,Wilke HJ,Blei- berg H,Van Den Brande J,Debois M,Bethe U,Van Cutsem E.Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first- line treatment of patients with metastatic colorectal cancer. EORTC study 40015. Annals of Oncology . 2008
10Rea DW,Nortier JW,Ten Bokkel Huinink WW,Falk S,Richel DJ,Maughan T,Groenewegen G,Smit JM,Steven N,Bakker JM,Semiond D,Kerr DJ,Punt CJ.A phase I/II and pharmaco- kinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer. Annals of Oncology . 2005
